Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Pediatric Endocrinology and Metabolism

Editor-in-Chief: Kiess, Wieland

Ed. by Bereket, Abdullah / Darendeliler, Feyza / Dattani, Mehul / Gustafsson, Jan / Luo, Fei Hong / Mericq, Veronica / Toppari, Jorma


IMPACT FACTOR 2018: 1.239

CiteScore 2018: 1.22

SCImago Journal Rank (SJR) 2018: 0.507
Source Normalized Impact per Paper (SNIP) 2018: 0.562

Online
ISSN
2191-0251
See all formats and pricing
More options …
Volume 27, Issue 3-4

Issues

Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature

Soultana Kolyva / Alexandra Efthymiadou / Despoina Gkentzi / Afroditi Karana-Ginopoulou / Anastasia Varvarigou
Published Online: 2013-08-10 | DOI: https://doi.org/10.1515/jpem-2013-0244

Abstract

Hypercalcemia is rare in children with etiology different from adults. We report an 11.5-year-old boy with developmental delay that presented with difficulty in walking and vomiting. Laboratory investigations revealed hypercalcemia (Ca 13.8 mg/dL) with low serum parathormone, normal full blood count and no circulating blasts. Osteolytic lesions were discovered on radiological survey. Bone marrow examination was consistent with the diagnosis of common B acute lymphoblastic leukemia (ALL). Hypercalcemia was successfully treated with zoledronic acid. Hypercalcemia is a rare but well-recognized complication of ALL, usually present at the time of initial diagnosis. We reviewed the literature and analyzed the clinical and laboratory data in 36 cases of childhood ALL presenting with hypercalcemia. In conclusion, hypercalcemia alone or combined with osteolytic lesions can be the only presenting symptom of ALL in children.

Keywords: acute lymphoblastic leukemia; children; hypercalcemia; zoledronic acid

References

  • 1.

    Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 2005;352:373–9.CrossrefPubMedGoogle Scholar

  • 2.

    McKay C, Furman WL. Hypercalcemia complicating childhood malignancies. Cancer 1993;72:256–60.CrossrefPubMedGoogle Scholar

  • 3.

    Jacobs TP, Bilezikian JP. Clinical review: Rare causes of hypercalcemia. J Clin Endocrinol Metab 2005;90:6316–22.PubMedCrossrefGoogle Scholar

  • 4.

    Shane E, Dinaz I. Hypercalcemia: pathogenesis, clinical manifestations, differential diagnosis, and management. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th ed. Philadelphia: Lippincott, Williams and Wilkins, 2006:176–80.Google Scholar

  • 5.

    Lietman SA, Germain-Lee EL, Levine MA. Hypercalcemia in children and adolescents. Curr Opin Pediatr 2010;22:508–15.PubMedCrossrefGoogle Scholar

  • 6.

    Myers WP. Clinical aspects and management of hypercalcemia. Med Clin North Am 1956;40:871–85.PubMedGoogle Scholar

  • 7.

    Kerdudo C, Aerts I, Fattet S, Chevret L, Pacquement H, et al. Hypercalcemia and childhood cancer: a 7-year experience. J Pediatr Hematol Oncol 2005;27:23–7.PubMedCrossrefGoogle Scholar

  • 8.

    Kounami S, Yoshiyama M, Nakayama K, Hiramatsu S, Aoyaqi N, et al. Severe hypercalcemia in a child with acute nonlymphocytic leukemia: the role of parathyroid hormone-related protein and proinflammatory cytokines. Acta Haematol 2004;112:160–3.CrossrefGoogle Scholar

  • 9.

    Qayed M, Ahmed I, Valentini RP, Cushing B, Rajpurkar M. Hypercalcemia in pediatric acute megakaryocytic leukemia: case report and review of the literature. J Pediatr Hematol Oncol 2009;31:373–6.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 10.

    Hibi S, Funaki H, Ochiai-Kanai R, Ikushima S, Todo S, et al. Hypercalcemia in children presenting with acute lymphoblastic leukemia. Int J Hematol 1997;66:353–7.CrossrefPubMedGoogle Scholar

  • 11.

    Inukai T, Hirose K, Inaba T, Kurosawa H, Hama A, et al. Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19. Leukemia 2007;21:288–96.CrossrefWeb of ScienceGoogle Scholar

  • 12.

    Soni PN. Hypercalcaemia and multiple osteolytic lesions in childhood acute lymphoblastic leukemia. Postgrad Med J 1993;69:483–5.CrossrefPubMedGoogle Scholar

  • 13.

    Shanks D, Linke R, Saxon B. Bones, groans and blasts. J Paediatr Child Health 2001;37:504–6.CrossrefPubMedGoogle Scholar

  • 14.

    Turker M, Oren H, Yilmaz S, Cakmakci H, Demircioglu F, et al. Unusual presentation of childhood acute lymphoblastic leukemia: a case presenting with hypercalcemia symptoms only. J Pediatr Hematol Oncol 2004;26:116–7.CrossrefPubMedGoogle Scholar

  • 15.

    Sultan I, Kraveka JM, Lazarchik J. CD19 negative precursor B acute lymphoblastic leukemia presenting with hypercalcemia. Pediatr Blood Cancer 2004;43:66–9.CrossrefWeb of ScienceGoogle Scholar

  • 16.

    Buonuomo PS, Ruggiero A, Piastra M, Riccardi R, Polidori G, et al. A case of acute lymphoblastic leukemia presenting as severe hypercalcemia. Pediatr Hematol Oncol 2004;21:475–9.PubMedCrossrefGoogle Scholar

  • 17.

    Lankisch P, Kramm CM, Hermsen D, Wessalowski R. Hypercalcemia with nephrocalcinosis and impaired renal function due to increased parathyroid hormone secretion at onset of childhood acute lymphoblastic leukemia. Leuk Lymphoma 2004;45:1695–7.CrossrefPubMedGoogle Scholar

  • 18.

    Andiran N, Alikasifoglu A, Kupeli S, Yetgin S. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature. Turk J Pediatr 2006;48:248–52.PubMedGoogle Scholar

  • 19.

    Oloomi Z. Acute lymphoblastic leukemia without circulating blasts presenting as severe hypercalcemia. Acta Med Iran 2007;45:76–8.Google Scholar

  • 20.

    Mittal MK. Severe hypercalcemia as a harbinger of acute lymphoblastic leukemia. Pediatr Emerg Care 2007;23:397–400.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 21.

    Bhat GM. A child with acute lymphoblastic leukemia presenting with symptomatic hypercalcemia and multiple osteolytic lesions. Indian J Med Paediatr Oncol 2007;28:46–7.Google Scholar

  • 22.

    Trehan A, Cheetham T, Bailey S. Hypercalcemia in acute lymphoblastic leukemia: an overview. J Pediatr Hematol Oncol 2009;31:424–7.CrossrefPubMedGoogle Scholar

  • 23.

    Ganesan P, Thulkar S, Gupta R, Bakhshi S. Childhood aleukemic leukemia with hypercalcemia and bone lesions mimicking metabolic bone disease. J Pediatr Endocrinol Metab 2009;22:463–7.PubMedGoogle Scholar

  • 24.

    Taskesen M, Okur N, Soker M, Tas MA. An unusual diagnosis in a child presenting with hypercalcemia: acute lymphoblastic leukemia. Gullhane Med J 2010;52:47–8.Google Scholar

  • 25.

    El Saleeby CM, Grottkau BE, Friedmann AM, Westra SJ, Sohani AR. Case records of the Massachusetts General Hospital. Case 4-2011. A 4-year-old boy with back pain and hypercalcemia. N Engl J Med 2011;364:552–62.Google Scholar

  • 26.

    Jamal CY, Islam MM, Rahman SA. Acute lymphoblastic leukemia presenting with severe hypercalcemia. Mymensingh Med J 2011;20:134–7.PubMedGoogle Scholar

  • 27.

    Rizzoli R, Ferrari SL, Pizurki L, Caverzasio J, Bonjour JP. Actions of parathyroid hormone and parathyroid hormone-related protein. J Endocrinol Invest 1992;15:51–6.PubMedGoogle Scholar

  • 28.

    Niizuma H, Fujii K, Sato A, Fujiwara I, Takeyama J, et al. PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19- negative precursor B acute lymphoblastic leukemia. Pediatr Blood Cancer 2007;49:990–3.CrossrefGoogle Scholar

  • 29.

    Todo S, Imashuku S, Inoda H, Yamanaka H, Hibi S, et al. Hypercalcemia in a case of childhood acute lymphoblastic leukemia. Jpn J Clin Oncol 1987;17:357–62.Google Scholar

  • 30.

    Hosking DJ, Cowley A, Bucknall CA. Rehydration in the treatment of severe hypercalcaemia. J Med 1981;50:473–81.Google Scholar

  • 31.

    Carano A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 1990;85:456–61.CrossrefPubMedGoogle Scholar

  • 32.

    Major P, Lortholary A, Hon J, Abdi E, Mills G. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 2001;19:558–67.PubMedGoogle Scholar

  • 33.

    Barros ER, Saraiva GL, De Oliveira TP, Lazaretti-Castro M. Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta. J Pediatr Endocrinol Metab 2012;25:485–91.Web of SciencePubMedGoogle Scholar

  • 34.

    Vuorimies I, Toiviainen-Salo S, Hero M, Makitie O. Zoledronic acid treatment in children with osteogenesis imperfecta. Horm Res Paediatr 2011;75:346–53.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 35.

    August KJ, Dalton A, Katzenstein HM, George B, Olson TA, et al. The use of zoledronic acid in pediatric cancer patients. Pediatr Blood Cancer 2011;56:610–4.CrossrefPubMedGoogle Scholar

About the article

Corresponding author: Anastasia Varvarigou, Professor of Pediatric and Neonatology, Department of Pediatrics, University General Hospital of Patras, Rio 26504, Patras, Greece, Phone: +30-26109993253, Fax: +30-2610994533, E-mail:


Received: 2013-06-13

Accepted: 2013-07-15

Published Online: 2013-08-10

Published in Print: 2014-03-01


Citation Information: Journal of Pediatric Endocrinology and Metabolism, Volume 27, Issue 3-4, Pages 349–354, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: https://doi.org/10.1515/jpem-2013-0244.

Export Citation

©2014 by Walter de Gruyter Berlin Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Ari Auron and Uri S. Alon
Pediatric Nephrology, 2017
[2]
Hye-Jin Park, Eun-Jin Choi, and Jin-Kyung Kim
Annals of Pediatric Endocrinology & Metabolism, 2016, Volume 21, Number 2, Page 99
[3]
Anar Tagiyev, Huseyin Demirbilek, Betul Tavil, Gonul Buyukyilmaz, Fatma Gumruk, and Mualla Cetin
Journal of Pediatric Hematology/Oncology, 2016, Volume 38, Number 3, Page 232

Comments (0)

Please log in or register to comment.
Log in